Derijks LJJ - Search Results

1

6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients.

Meijer B, Kreijne JE, van Moorsel SAW, Derijks LJJ, Bouma G, Mulder CJJ, Wong DR, van der Woude CJ, van Bodegraven AA, de Boer NKH. Meijer B, et al. Among authors: derijks ljj. J Gastroenterol Hepatol. 2017 Jun;32(6):1183-1190. doi: 10.1111/jgh.13656. J Gastroenterol Hepatol. 2017. PMID: 27859568 Free article.

2

6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.

Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, Mulder CJ. Derijks LJ, et al. Eur J Gastroenterol Hepatol. 2003 Jan;15(1):63-7. doi: 10.1097/00042737-200301000-00011. Eur J Gastroenterol Hepatol. 2003. PMID: 12544696 Clinical Trial.

3

Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.

Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, Curvers WL, Van Deventer SJ, Hommes DW, Hooymans PM. Derijks LJ, et al. Ther Drug Monit. 2004 Jun;26(3):311-8. doi: 10.1097/00007691-200406000-00016. Ther Drug Monit. 2004. PMID: 15167634 Clinical Trial.

4

Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients.

Gilissen LP, Derijks LJ, Bos LP, Verhoeven HM, Bus PJ, Hooymans PM, Engels LG. Gilissen LP, et al. Eur J Gastroenterol Hepatol. 2004 Jul;16(7):705-10. doi: 10.1097/01.meg.0000108333.52416.63. Eur J Gastroenterol Hepatol. 2004. PMID: 15201586

5

Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.

de Boer NK, van Nieuwkerk CM, Aparicio Pages MN, de Boer SY, Derijks LJ, Mulder CJ. de Boer NK, et al. Eur J Gastroenterol Hepatol. 2005 Apr;17(4):457-61. doi: 10.1097/00042737-200504000-00012. Eur J Gastroenterol Hepatol. 2005. PMID: 15756101 Review.

6

Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease.

Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, van Deventer SJ, Hommes DW, Hooymans PM. Derijks LJ, et al. Ther Drug Monit. 2006 Feb;28(1):45-50. doi: 10.1097/01.ftd.0000179839.71138.6d. Ther Drug Monit. 2006. PMID: 16418693 Clinical Trial.

7

Pharmacogenomics in inflammatory bowel disease.

Egan LJ, Derijks LJ, Hommes DW. Egan LJ, et al. Clin Gastroenterol Hepatol. 2006 Jan;4(1):21-8. doi: 10.1016/j.cgh.2005.10.003. Clin Gastroenterol Hepatol. 2006. PMID: 16431300 Review.

8

Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.

Zelinkova Z, Derijks LJ, Stokkers PC, Vogels EW, van Kampen AH, Curvers WL, Cohn D, van Deventer SJ, Hommes DW. Zelinkova Z, et al. Clin Gastroenterol Hepatol. 2006 Jan;4(1):44-9. doi: 10.1016/j.cgh.2005.10.019. Clin Gastroenterol Hepatol. 2006. PMID: 16431304

9

6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?

Derijks LJ, Gilissen LP, de Boer NK, Mulder CJ. Derijks LJ, et al. J Hepatol. 2006 Apr;44(4):821-2. doi: 10.1016/j.jhep.2005.11.049. Epub 2006 Jan 24. J Hepatol. 2006. PMID: 16487623 No abstract available.

10

Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?

Derijks LJ, Hommes DW. Derijks LJ, et al. Curr Gastroenterol Rep. 2006 Apr;8(2):89-92. doi: 10.1007/s11894-006-0001-0. Curr Gastroenterol Rep. 2006. PMID: 16533469 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters